Company / Shares Outstanding
Travere Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
87.5M
FY2025
5-year range
52.2M / 87.5M
FY2021-FY2025
Trend
+16.0%
vs FY2024
Sector context
#112 of 212
Health Care
What the data says
At 87452835.00, Travere Therapeutics, Inc.'s shares outstanding ranks #101 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 36465853.00 in FY2016 to 87452835.00 in FY2025.
Based on SEC 10-K filings.
87452835.00 in FY2025 with a 5-year CAGR of +15.2%.
Increased from 64290570.00 to 87452835.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
#101 of 212 in Health CareTop 47% of 212This company 87.5M Sector average 306.7M
▼
-71.5% below sector average
Key checks
Key Insights
- Travere Therapeutics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 16.0% year-over-year.
- Ranks #112 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 87.5M | +16.0% |
| FY2024 | 75.4M | +17.2% |
| FY2023 | 64.3M | +2.9% |
| FY2022 | 62.5M | +19.6% |
| FY2021 | 52.2M | +21.3% |
| FY2020 | 43.1M | +4.1% |
| FY2019 | 41.4M | +5.1% |
| FY2018 | 39.4M | +3.9% |
| FY2017 | 37.9M | +4.0% |
| FY2016 | 36.5M | +40.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026